Todd Harris - Sep 13, 2024 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role
President and CEO, Director
Signature
/s/ Ali D. Fawaz, Attorney-in-Fact
Stock symbol
TYRA
Transactions as of
Sep 13, 2024
Transactions value $
$8,882
Form type
4
Date filed
9/17/2024, 05:15 PM
Previous filing
Aug 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TYRA Common Stock Award $8.88K +1.35K +0.09% $6.58 1.51M Sep 13, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.